ETF Copies Hedgies,...
Health Care: Drugs
Teva Pharmaceutical Industries Ltd (TEVA: NYSE)
$40.21 0.02 | 0.05%
05/21/13 - 04:02 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with TEVA
- Portfolio NameUser Type
- UserDonnie Portfolio 2 High Grade
- UserMain
- UserLong Term Stock Picks
- UserTRIG
- Userfun and games
- Userabangser Portfolio 1
- ContributorHighest-Yielding Drug Stocks
- Contributor8 Pharma Stocks to Watch
- Userdividend
- UserIncome stocks
Latest TEVA Headlines from TheStreet
- Teva Pharmaceutical Industries Ltd Stock Hold Recommendation Reiterated (TEVA) 04.18.13 | 10:04 am
- 5 Stocks Pulling The Drugs Industry Downward 04.12.13 | 01:04 pm
- Cramer's Top Stock Picks: BMY TEVA ROST BBBY 04.12.13 | 06:04 am
- Cramer's 'Mad Money' Recap: Bubble? What Bubble? 04.11.13 | 08:04 pm
- Teva Pharmaceutical Industries Ltd Stock Hold Recommendation Reiterated (TEVA) 04.08.13 | 10:04 am
- 3 Stocks Improving Performance Of The Health Care Sector 04.03.13 | 01:04 pm
- Teva Pharmaceutical Industries Ltd Stock Hold Recommendation Reiterated (TEVA) 03.28.13 | 10:03 am
- 4 Stocks Dragging The Drugs Industry Downward 03.27.13 | 01:03 pm
- Teva Pharmaceutical Industries Ltd Stock Hold Recommendation Reiterated (TEVA) 03.18.13 | 10:03 am
- Analysts' Actions: BTU HLS HPQ ODP TEVA 03.18.13 | 08:03 am
Press Releases for TEVA
- Apolo Anton Ohno And Teva Respiratory Announce Finalists In National EIB All Starsâ¿¢ Contest - PR Newswire 04.16.13 | 08:04 am
- OncoGenex Announces Plans For The Initiation Of The Spruceâ¿¢ Clinical Trial Evaluating OGX-427 In Combination With Chemotherapy In Advanced Non-Squamous Non-Small Cell Lung Cancer - PR Newswire 04.11.13 | 08:04 am
- Early Versus Delayed Treatment With Laquinimod Demonstrated Significant Reduction In Risk Of Disability Progression – Results Of Three-Year ALLEGRO Study In Relapsing-Remitting Multiple Sclerosis - Business Wire 03.21.13 | 08:03 am
- New Data Show Azilect® (rasagiline Tablets) Provided Clinical Benefit In Patients With Early Parkinson’s When Added To Sub-Optimally Controlled Patients On Dopamine Agonist Therapy - Business Wire 03.20.13 | 07:03 am
- Teva To Present New Research On CNS Product Portfolio And Pipeline At 2013 American Academy Of Neurology Annual Meeting - Business Wire 03.14.13 | 09:03 am
- Clay Walker, Country Music Star And Relapsing-Remitting Multiple Sclerosis Patient Urges Others To "Stick With It" - PR Newswire 03.13.13 | 08:03 am
- Teva Files 2012 Annual Report On Form 20-F - Business Wire 03.08.13 | 04:03 pm
- First Patient Enrolled In Third Phase III Study Of Oral Laquinimod For Relapsing-Remitting Multiple Sclerosis - Business Wire 03.06.13 | 08:03 am
- Phase III Study Of Teva’s Milprosa™ (Progesterone) Vaginal Ring Published In Fertility And Sterility - Business Wire 03.04.13 | 08:03 am
- Teva Calls 5.550% Senior Notes Due 2016 For Redemption - Business Wire 03.01.13 | 09:03 am
Partner Headlines for TEVA
- Analysts: SanDisk Will Beat Estimates and 4 New Opinions Investors Must Take Note Of - Wall St. Cheat Sheet 04.02.13 | 11:04 am
- 10 Sharp Healthcare Dogs Diagnose 7.4% To 62.1% Gains In March - Seeking Alpha 04.01.13 | 09:04 am
- FDA Approves NDA for Teva's Quartette Tablets to Prevent Pregnancy - Benzinga 03.29.13 | 11:03 am
- Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy - Seeking Alpha 03.28.13 | 09:03 am
- Biogen MS Drug Approved; No 'Black Box' Label - Investor's Business Daily 03.27.13 | 06:03 pm
- Drug Companies Have Rebounded From The Patent Cliff With Acquisitions Now On The Mind - Seeking Alpha 03.25.13 | 09:03 am
- Valeant Earnings, Sales Top Estimates; Street Shrugs - Investor's Business Daily 02.28.13 | 05:02 pm
- 3 Industries Set To Profit From An Aging Population - Seeking Alpha 01.31.13 | 09:01 am
- Amgen Q4 Sales, 2013 Guidance Modestly Beat Estimates - Investor's Business Daily 01.23.13 | 06:01 pm
- Teva Pharmaceuticals - Food For Thought - Seeking Alpha 01.15.13 | 08:01 am
